Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy

Pfizer · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
gene-therapy
muscular dystrophy, duchenne, early stage duchenne muscular dystrophy, dmd, gene therapy, fordadistrogene movaparvovec, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834914
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.